European guidelines have traditionally defined normal blood pressure as a reading below 130/85 mmHg when measured in a clinic, with a further distinction between “optimal” (below 120/80) and “normal” (120–129/80–84). That framework, used by the European Society of Hypertension since 2018, was overhauled in 2024 when the European Society of Cardiology introduced a simplified two-tier system that reclassifies everyone into either “not elevated” (below 120/70) or “elevated” (120–139/70–89). The shift matters because millions of Europeans who were previously labeled “normal” now fall into the elevated category, and the thresholds sit in a different place than those used in the United States.
How European Blood Pressure Categories Work
Until recently, European practice followed the 2018 European Society of Hypertension (ESH) classification. It split the below-hypertension range into three buckets: optimal blood pressure sat below 120/80 mmHg, normal covered 120–129 systolic and 80–84 diastolic, and high-normal ran from 130–139 systolic and 85–89 diastolic. Hypertension itself began at 140/90 mmHg and was graded into three severity levels depending on how far above that line you sat.1PubMed Central. New American and European Hypertension Guidelines, Reconciling the Differences
The 2024 European Society of Cardiology (ESC) guidelines collapsed those three sub-hypertension categories into two. “Not elevated” now means systolic below 120 and diastolic below 70, while “elevated” covers 120–139 systolic and 70–89 diastolic.2PubMed. Reclassification of patients with normal blood pressure levels after 2024 European society of cardiology guidelines on hypertension The practical effect is that the diastolic floor for the “not elevated” label dropped from 80 to 70, and the old “normal” and “high-normal” zones merged into a single “elevated” band. If your blood pressure is 125/75, you went from “normal” under the old system to “elevated” under the new one.
Hypertension itself is still defined as 140/90 mmHg or higher in European practice. That threshold has remained remarkably stable across multiple guideline revisions, even as treatment targets have drifted lower for many patient groups.3PubMed Central. The Evolution of Blood Pressure Thresholds and Targets over Time: A Historical Review
Where Europe and the United States Disagree
The biggest transatlantic split is straightforward: American guidelines, updated in 2017 by the ACC/AHA, lowered the hypertension threshold to 130/80 mmHg. European guidelines kept it at 140/90.4PubMed. European and US guidelines for arterial hypertension: similarities and differences That ten-point gap in systolic pressure reclassifies a huge number of people. Someone with a reading of 135/82 is hypertensive under US rules but falls into the “elevated” (previously “high-normal”) category in Europe and would not automatically qualify for drug treatment.
The disagreement extends to treatment targets. US guidelines generally want blood pressure driven below 130/80 in everyone. European guidelines aim for that target only in people at high cardiovascular risk, while the general population target is below 140/90, with a preference for getting systolic into the 120–129 range when tolerated.5PubMed. ACC/AHA Versus ESC/ESH on Hypertension Guidelines: JACC Guideline Comparison The European approach is more individualized: it factors in age, frailty, side effects, and overall cardiovascular risk before pushing for aggressive targets.
The 2024 ESC update nudged European practice closer to the American position by setting a default systolic treatment target of 120–129 mmHg for most patients, while still allowing relaxed goals for people over 85, those with frailty, or anyone who does not tolerate lower pressures well.6PubMed Central. What Is New and Different in the 2024 European Society of Cardiology Guidelines for the Management of Elevated Blood Pressure and Hypertension? So while the diagnostic threshold stays at 140/90, the on-treatment goal for most people is now closer to what US guidelines recommend.
What Counts as Normal When You Measure at Home
The numbers above all refer to office blood pressure, meaning readings taken in a clinic by a healthcare professional. If you use a home blood pressure monitor, the thresholds are different. European Society of Hypertension practice guidelines state that an average home reading of 135/85 mmHg or higher indicates hypertension.7Journal of Hypertension. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement – Section: HOME BP MONITORING (HBPM) The reason for the lower cutoff is that blood pressure tends to run a few points higher in a clinic setting, partly due to stress and partly due to methodological differences. “Normal” at home is therefore roughly 5 mmHg lower on both systolic and diastolic sides compared with in-office normal.
Home monitoring has become increasingly common in parts of Europe. A French national study found that about 21% of the general adult population owned a home blood pressure device, rising to roughly 42% among people already diagnosed with hypertension and 54% among those who were aware of their diagnosis.8Europe PMC. Home blood pressure monitoring in France: Device possession rate and associated determinants, the Esteban study. Ownership was higher among women, smokers, and people who visited their general practitioner regularly. These numbers are from one country, and uptake varies across Europe, but the general direction is clear: more people are tracking their own blood pressure, which makes knowing the correct home threshold important.
White-Coat and Masked Hypertension
A recurring problem in blood pressure classification is that your reading can shift depending on where and when it is taken. White-coat hypertension refers to people whose blood pressure reads high in the clinic but normal at home. Masked hypertension is the opposite: normal in the clinic, elevated at home or during daily life. Both conditions are common. Across international registries, roughly one in three people with elevated office readings turn out to have white-coat hypertension, and a similar proportion of those with controlled office readings actually have masked hypertension.9Hypertension Research. Prevalence of white-coat and masked hypertension in national and international registries
The cardiovascular stakes differ between the two. In a large international study following participants for a median of about eight years, untreated people with white-coat hypertension had roughly 40% higher cardiovascular risk than true normotensives, while those with masked hypertension had about 55% higher risk. Among people already on medication, masked hypertension remained dangerous, raising cardiovascular event risk by about 76% compared with those whose blood pressure was well controlled both in and out of the clinic.10PubMed. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome The practical upshot is that a single office reading does not tell the full story. European guidelines now strongly encourage out-of-office measurement, whether through home monitors or 24-hour ambulatory devices, before making treatment decisions.
How Age Changes the Picture
Blood pressure naturally rises with age as arteries stiffen, and European guidelines adjust their expectations accordingly. For most adults, the 2024 ESC guidelines aim for treated systolic blood pressure in the 120–129 range. But for adults 85 and older, or anyone with moderate-to-severe frailty, the recommendation is more flexible: get blood pressure as low as is reasonably achievable without causing symptoms like dizziness or falls.6PubMed Central. What Is New and Different in the 2024 European Society of Cardiology Guidelines for the Management of Elevated Blood Pressure and Hypertension?
Earlier ESH guidance was more explicit about specific numbers for older people. For those over 80, treatment was recommended when systolic pressure reached 160 mmHg or higher, with a target of 140–150. Fit patients under 80 could be treated starting at 140, aiming for below 140 if tolerated. For frail older adults, the ESH advised basing decisions on individual health status rather than fixed numbers.11PubMed. Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets The general trend in European practice has been to push treatment targets lower over time, but always with escape clauses for the very old and the frail.
Children and Adolescents in Europe
For children, “normal” blood pressure is not a single number but a moving target defined by percentile charts that account for age, sex, and height. A reading at or above the 95th percentile for the child’s demographic group is considered hypertensive. European-specific reference data from the IDEFICS study, which covered non-overweight school-age children across multiple European countries, showed that blood pressure rises with both age and height. In younger children (under five), girls tended to have slightly higher systolic values than boys; after that age, boys overtook girls.12International Journal of Obesity. Blood pressure reference values for European non-overweight school children: The IDEFICS study
By adolescence, the numbers start converging toward adult thresholds. European data from the HyperChildNET project found that the 95th percentile for systolic blood pressure at age 13 is close to 130/80 in both sexes, and by age 17 it reaches around 140/90 for boys at median height.13Journal of Clinical and Translational Endocrinology. Blood pressure values, percentiles, and methods in European children and adolescents: Results from the COST Action HyperChildNET The study also highlighted that measurement method matters: oscillometric devices (the automated kind most clinics use) and traditional auscultatory measurements can yield different percentile values, which is something to be aware of when comparing readings from different settings.
Weight plays a significant role. A German study of over 22,000 children and adolescents found that blood pressure percentiles for overweight and obese youth were substantially higher than those for normal-weight peers. At the 90th percentile, a 17-year-old overweight male had readings around 148/91, compared with 136/86 in a normal-weight peer.14American Journal of Hypertension. Blood Pressure Percentiles in 22,051 German Children and Adolescents: The PEP Family Heart Study This is why pediatric guidelines emphasize using weight-specific reference charts rather than a single universal table.
Blood Pressure Varies Across Europe
Hypertension rates are not uniform across the continent. A pooled analysis of over 68,000 adults from 27 European countries found consistent regional patterns. Central and Eastern Europe, along with Southern Europe, had higher hypertension prevalence than Northern and Western Europe, with the gaps widening with age. Among women aged 65–79, for instance, roughly 73% in Central and Eastern Europe had hypertension, compared with about 54% in Western Europe. Among men in the same age group, Southern Europe led at about 74%, versus roughly 56% in Northern and Western Europe.15Preventive Medicine Reports. Prevalence of hypertension in Europe: a pooled analysis of 68,047 adults from 27 countries
These differences reflect a mix of dietary habits, healthcare access, obesity rates, and possibly genetic factors. Salt intake is one well-studied contributor. A modeling study estimated that average daily salt consumption ranged from about 9 grams per day in Finland to over 13 grams in Poland for men. The same study projected that a 30% reduction in salt intake could cut stroke prevalence by anywhere from about 6% in Finland to nearly 14% in Poland.16PLoS ONE. Health Gain by Salt Reduction in Europe: A Modelling Study Systolic blood pressure levels tracked with salt intake and regional patterns: the lowest average readings were found in Sweden, while the highest among men were in France and among women in Poland.
Blood Pressure and Women’s Cardiovascular Health
Women’s blood pressure follows a distinct trajectory across the lifespan, and the menopause transition is a period of particular change. A long-running study tracking women’s blood pressure over nearly 30 years found that about a third of women followed a trajectory where systolic blood pressure rose slowly before menopause but showed an accelerated increase starting about one year after their final menstrual period.17PubMed Central. Trajectories of Blood Pressure in Midlife Women: Does Menopause Matter? Not all women followed this pattern; roughly half showed a steady, moderate linear rise regardless of menopausal timing, and about 17% were already in the high range but actually saw a slow decline after menopause.
A separate longitudinal study of nearly 4,000 women found that the link between blood pressure and chronological age was stronger than the link between blood pressure and reproductive age (time relative to menopause). Systolic blood pressure rose by about 0.4 mmHg per year of chronological age but only about 0.1 mmHg per year of reproductive age, a difference that was not statistically significant for reproductive age.18PubMed Central. Cardiovascular health in the menopause transition: a longitudinal study of up to 3892 women with up to four repeated measures of risk factors The takeaway is that while menopause coincides with accelerating blood pressure in some women, the dominant driver is aging itself. European guidelines do not set different blood pressure thresholds for men and women, but awareness that midlife women may see rapid rises is clinically useful for catching hypertension early.
Seasonal Variation
Blood pressure is not the same reading year-round. A consensus statement from the European Society of Hypertension confirmed that blood pressure tends to be lower during warmer months and higher in cold weather. The effect is seen in both sexes, all age groups, and in people with and without hypertension.19Journal of Hypertension. Seasonal variation in blood pressure: Evidence, consensus and recommendations for clinical practice The swing can be large enough to push someone across a diagnostic threshold in winter who would be classified as normal in summer. For anyone monitoring blood pressure at home, this means that a single reading in January and a single reading in July are not directly comparable without accounting for temperature.
This has practical implications across Europe’s varied climates. A person in Scandinavia during a harsh winter may see meaningfully higher readings than the same person on holiday in southern Spain. European guidelines acknowledge this variability, though no formal seasonal adjustment to diagnostic thresholds has been adopted. The recommendation is simply to interpret borderline readings in context and to rely on repeated measurements over time rather than any single snapshot.
Cuffless Devices and the Future of Measurement
Smartwatches and smartphone apps that claim to measure blood pressure without a traditional cuff have generated enormous consumer interest, but European regulators are cautious. A 2021 assessment from the European Society of Hypertension found serious accuracy concerns with cuffless devices and explicitly recommended against their use for clinical decision-making.20PubMed Central. Evaluation of the Accuracy of Cuffless Blood Pressure Measurement Devices: Challenges and Proposals The core problem is that these devices use indirect methods, usually estimating blood pressure from pulse characteristics detected by optical sensors, and no standardized validation protocol exists to confirm they work reliably across different populations.
The European Society of Hypertension has since published recommendations for how cuffless devices should be validated, acknowledging that the technology is heterogeneous in its principles, intended uses, and calibration requirements.21Journal of Hypertension. European Society of Hypertension recommendations for the validation of cuffless blood pressure measuring devices Until devices pass robust validation, your best option for home monitoring remains a standard upper-arm cuff monitor that has been independently tested. If you are comparing your home readings against European thresholds, you need a device that measures in the same way the thresholds were derived, and right now, that means a cuff.
Why Average Blood Pressure Level Matters More Than Fluctuation
You might assume that blood pressure swinging up and down between visits is itself a danger sign, independent of where the average sits. The evidence from European trials suggests otherwise, at least when blood pressure is not severely elevated. In the Systolic Hypertension in Europe trial, visit-to-visit variability in blood pressure was not independently associated with cardiovascular events once the average level was accounted for.22PLoS ONE. Randomised Double-Blind Comparison of Placebo and Active Drugs for Effects on Risks Associated with Blood Pressure Variability in the Systolic Hypertension in Europe Trial Similarly, the European Lacidipine Study on Atherosclerosis found that among people with mild to moderate hypertension, cardiovascular outcomes tracked with the average blood pressure achieved on treatment rather than with how much readings bounced around between clinic visits.23PubMed. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis
The practical lesson: if your home readings vary from 118/72 one day to 132/78 the next, what matters most for your long-term risk is the average over weeks, not whether individual readings occasionally spike. This is another reason European guidelines emphasize repeated measurements and home averages rather than reacting to any single reading.
Central Blood Pressure and Emerging Measures
Standard blood pressure measurement captures pressure in the brachial artery of your upper arm. But pressure is not the same everywhere in your circulatory system. Aortic (central) systolic pressure is typically lower than the brachial reading, and the gap between the two varies from person to person. Research published in the European Heart Journal has found emerging evidence that central blood pressure may predict future cardiovascular events better than the arm reading, and that some blood pressure drugs affect central and arm pressures differently.24PubMed Central. Central blood pressure: current evidence and clinical importance
Another measure gaining attention in European research is pulse wave velocity, which gauges how fast pressure waves travel along the aorta as a proxy for arterial stiffness. A study using a large European reference population found that this measure had prognostic value for cardiovascular events beyond what traditional risk factors alone could predict.25PubMed. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population Neither central blood pressure nor pulse wave velocity has replaced standard arm-cuff measurement in routine European clinical practice, but both are already used in specialized settings and may become part of risk assessment in future guideline revisions. For now, the arm-cuff number and its associated thresholds remain the foundation of what “normal” means in Europe.